1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Tafolecimab in Hyperlipidemia: A Study of Different Dosing IntervalsDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, metabolic diseaseNot yet recruitingNot stated2026-07-17NCT07712042